Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mian Gao

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular and Biochemical Parasitology|November 28, 2006
Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organismsMasoud Vedadi, Jocelyne Lew, Jennifer Artz, et al.
Journal of Medicinal Chemistry|June 15, 2022
Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic SteatohepatitisSusheel J Nara, Srinivas Jogi, Srinivas Cheruku, et al.
Journal of Medicinal Chemistry|December 2, 2020
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design ApproachesHai-Yun Xiao, Ning Li, James J-W Duan, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular and Biochemical Parasitology|November 28, 2006
Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organismsMasoud Vedadi, Jocelyne Lew, Jennifer Artz, et al.
Journal of Medicinal Chemistry|June 15, 2022
Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic SteatohepatitisSusheel J Nara, Srinivas Jogi, Srinivas Cheruku, et al.
Journal of Medicinal Chemistry|December 2, 2020
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design ApproachesHai-Yun Xiao, Ning Li, James J-W Duan, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 4